Status: Recruiting
Adrenoleukodystrophy National Registry Study
The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected using this registry.
Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Masonic Cancer Center, University of MinnesotaUpdated: May 12, 2026Locations: 1Duration: 99 Years
Eligibility criteria
Age 0 - 100 [+3]
Patients diagnosed with ALD who lack the capacity to consent/assent AND do not h... [+4]